Loading news...
Angitia Biopharmaceuticals raised $40M Series B venture round, led by Guangzhou High-tech Control.
This funding round does not have an about section yet.
| Investor |
|---|
| Firm Type |
|---|
| Partner |
|---|
| Venture Capital | — | |
Yuekai CapitalLEAD | Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$336M
Top Valuation
-
Angitia Biopharmaceuticals raised $40M in a Series B round.
The round was announced on 02/28/24.
The round was led by Guangzhou High-tech Control, Zhuoyue (卓粤) Li (李).